Yury Popov, MD, PhD - Harvard Medical School - Assistant Professor of Medicine

Yury Popov

MD, PhD

Harvard Medical School

Assistant Professor of Medicine

Boston, Massachusetts | United States

Main Specialties: Biology, Biotechnology, Gastroenterology, Hepatology, Oncology, Pharmacology

Additional Specialties: Gastroenterology and Hepatology

ORCID logohttps://orcid.org/0000-0001-7973-942X


Top Author

Yury Popov, MD, PhD - Harvard Medical School - Assistant Professor of Medicine

Yury Popov

MD, PhD

Introduction

Yury Popov received an M.D. (1997) from Grodno State Medical School, Belarus and PhD in Biochemistry (2004) from Institute of Biochemistry of National Academy of Sciences of Belarus. He was the first scientist from Eastern Europe to win the prestigious Sheila Sherlock EASL fellowship award to pursue postdoctoral training in translational liver fibrosis research at the University of Erlangen-Nuremberg in Germany. In 2005, Dr. Popov relocated to USA and joined faculty at Beth Israel Deaconess Medical Center and Harvard Medical School. He is the recipient of a number of industry, foundations and institutional grants. Dr. Popov is currently directing a Liver Fibrosis Research Lab and Core and holding an appointment of Assistant Professor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. He is also an Associate Editor of American Journal of Physiology-Gastrointestinal and Liver Physiology, and ad hoc reviewer for over 30 scientific journals and funding agencies in US and abroad.

Primary Affiliation: Harvard Medical School - Boston, Massachusetts , United States

Specialties:

Additional Specialties:

Research Interests:

Education

Jan 2001 - Feb 2005
Friedrich-Alexander-Universitat Erlangen-Nurnberg
Sheila Sherlock EASL Postdoctoral Fellow
Department of Medicine I
Aug 1997 - Nov 2004
National Academy of Sciences of Belarus
Ph.D. in Biochemistry
Institute of Biochemistry
Sep 1991 - Jun 1997
Grodno State Medical University
M.D.

Experience

Feb 2005
Beth Israel Deaconess Medical Center, Harvard Medical School
Assistant Professor of Medicine
Medicine

Publications

58Publications

1297Reads

3190Profile Views

1022PubMed Central Citations

Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.

Purinergic Signal 2018 03 13;14(1):37-46. Epub 2017 Nov 13.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11302-017-9590-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842151PMC
March 2018
47 Reads
3.890 Impact Factor

Optimized Mouse Models for Liver Fibrosis.

Methods Mol Biol 2017 ;1559:279-296

Institute of Translational Immunology and Research Center for Immune Therapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6786-5_19DOI Listing
January 2018
15 Reads
2 Citations

Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.

Gut 2017 09 10;66(9):1697-1708. Epub 2017 Jan 10.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2016-312473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561383PMC
September 2017
85 Reads
18 Citations
14.660 Impact Factor

Letter: would aspirin alleviate fibrosis in alcoholic liver disease? Authors' reply.

Jiang ZG, Feldbrügge L, Tapper EB, Popov Y, Ghaziani T, Afdhal N, Robson SC, Mukamal KJ, Alimentary pharmacology & therapeutics, 2016, vol. 44, no. 2, pp. 209-210, 2016

http://europepmc.org/abstract/med/27296690

View Article
July 2016
4 Reads

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.

FASEB J 2016 Apr 23;30(4):1599-609. Epub 2015 Dec 23.

*Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Gilead Sciences, Inc., Foster City, California, USA; and Institute of Translational Immunology, University Medical Center, Mainz, Germany

View Article

Download full-text PDF

Source
http://www.fasebj.org/content/early/2015/12/22/fj.14-268425.
Web Search
http://www.fasebj.org/cgi/doi/10.1096/fj.14-268425
Publisher Site
http://dx.doi.org/10.1096/fj.14-268425DOI Listing
April 2016
48 Reads
16 Citations
5.043 Impact Factor

Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.

Aliment Pharmacol Ther 2016 Mar 7;43(6):734-43. Epub 2016 Jan 7.

Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/apt.13515
Publisher Site
http://dx.doi.org/10.1111/apt.13515DOI Listing
March 2016
16 Reads
3 Citations
5.730 Impact Factor

Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis.

Hepatology 2016 Jan 23;63(1):217-32. Epub 2015 Nov 23.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.28274
Publisher Site
http://dx.doi.org/10.1002/hep.28274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312042PMC
January 2016
38 Reads
13 Citations
11.055 Impact Factor

Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis.

Hepatology 2015 Oct 28;62(4):1285-97. Epub 2015 Aug 28.

Institute of Translational Immunology, University of Mainz Medical Center, Mainz, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.27936
Publisher Site
http://dx.doi.org/10.1002/hep.27936DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589454PMC
October 2015
28 Reads
11 Citations
11.055 Impact Factor

A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.

Am J Pathol 2015 Feb 2;185(2):325-34. Epub 2014 Dec 2.

Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2014.10.013DOI Listing
February 2015
38 Reads
6 Citations
4.591 Impact Factor

Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.

Gastroenterology 2014 Dec 28;147(6):1378-92. Epub 2014 Aug 28.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.08.038DOI Listing
December 2014
54 Reads
20 Citations
16.720 Impact Factor

Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

Gastroenterology 2014 Nov 30;147(5):1073-83.e6. Epub 2014 Jul 30.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.07.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570569PMC
November 2014
53 Reads
43 Citations
16.720 Impact Factor

Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.

Gastroenterology 2014 May 4;146(5):1339-50.e1. Epub 2014 Feb 4.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.01.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001704PMC
May 2014
47 Reads
49 Citations
16.720 Impact Factor

Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation.

Am J Pathol 2013 Jul 14;183(1):182-94. Epub 2013 May 14.

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029440130027
Publisher Site
http://dx.doi.org/10.1016/j.ajpath.2013.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702745PMC
July 2013
18 Reads
27 Citations
4.591 Impact Factor

Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis.

Am J Physiol Gastrointest Liver Physiol 2013 May 28;304(10):G876-84. Epub 2013 Mar 28.

Beth Israel Deaconess Medical Center, Dana 501, 330 Brookline Ave., Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00305.2012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652072PMC
May 2013
19 Reads
3 Citations
3.800 Impact Factor

Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

World J Gastroenterol 2013 May;19(19):2883-93

Centenary Institute and Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v19.i19.2883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660813PMC
May 2013
10 Reads
6 Citations
2.370 Impact Factor

Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet?

Authors:
Yury Popov

Hepatology 2013 Feb;57(2):429-31

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25969DOI Listing
February 2013
21 Reads
4 Citations
11.055 Impact Factor

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

Nat Biotechnol 2013 Jan 16;31(1):63-70. Epub 2012 Dec 16.

Harvard-MIT Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.2464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542405PMC
January 2013
31 Reads
37 Citations
41.514 Impact Factor

Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.

Hepatology 2012 Dec;56(6):2094-105

Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.25951
Publisher Site
http://dx.doi.org/10.1002/hep.25951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508175PMC
December 2012
32 Reads
5 Citations
11.055 Impact Factor

CFTR dysfunction predisposes to fibrotic liver disease in a murine model.

Am J Physiol Gastrointest Liver Physiol 2012 Aug 7;303(4):G474-81. Epub 2012 Jun 7.

Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00055.2012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423138PMC
August 2012
33 Reads
3 Citations
3.800 Impact Factor

Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity.

Hepatol Res 2012 Jun 11;42(6):601-10. Epub 2012 Jan 11.

Department of Surgery and Vascular Biology Program, Children's Hospital Boston, Harvard Medical School Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA Department of Surgery, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1872-034X.2011.00960.xDOI Listing
June 2012
39 Reads
7 Citations
2.220 Impact Factor

Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice.

PLoS One 2011 27;6(9):e25587. Epub 2011 Sep 27.

Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0025587PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181348PMC
January 2012
32 Reads
5 Citations
3.234 Impact Factor

Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.

Gastroenterology 2011 May 26;140(5):1642-52. Epub 2011 Jan 26.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2011.01.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374132PMC
May 2011
27 Reads
28 Citations
16.720 Impact Factor

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.

Hepatology 2011 Jan 26;53(1):230-42. Epub 2010 Oct 26.

Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.23999DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505073PMC
January 2011
47 Reads
33 Citations
11.055 Impact Factor

Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42.

Fibrogenesis Tissue Repair 2011 Jan 6;4(1). Epub 2011 Jan 6.

Department of Gastroenterology and Hepatology, Charité, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-1536-4-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024946PMC
January 2011
20 Reads
6 Citations

Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive?

Gastroenterology 2010 Sep 1;139(3):722-5. Epub 2010 Aug 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2010.07.015DOI Listing
September 2010
11 Reads
14 Citations
16.720 Impact Factor

Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.

PLoS One 2010 Jun 25;5(6):e11256. Epub 2010 Jun 25.

Department of Surgery and Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011256PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892485PMC
June 2010
60 Reads
11 Citations
3.234 Impact Factor

Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

Am J Physiol Gastrointest Liver Physiol 2010 Mar 7;298(3):G323-34. Epub 2010 Jan 7.

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00394.2009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838516PMC
March 2010
46 Reads
36 Citations
3.800 Impact Factor

CD8+ T cells drive adipose tissue inflammation--a novel clue for NASH pathogenesis?

J Hepatol 2010 Jan 29;52(1):130-2. Epub 2009 Oct 29.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2009.10.019DOI Listing
January 2010
16 Reads
3 Citations
11.340 Impact Factor

Rationale and targets for antifibrotic therapies.

Schuppan D, Popov Y, Gastroenterologie clinique et biologique, 2009, vol. 33, no. 10-11, pp. 949-957

http://europepmc.org/abstract/med/19726145

View Article
2009
6 Reads

Role of the receptor for advanced glycation end products in hepatic fibrosis.

World J Gastroenterol 2009 Dec;15(46):5789-98

Department of Medicine I, University of Erlangen-Nuremberg, Erlangen-Nürnberg, D-91054, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791271PMC
December 2009
11 Reads
11 Citations
2.370 Impact Factor

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

Hepatology 2009 Oct;50(4):1294-306

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.23123DOI Listing
October 2009
14 Reads
84 Citations
11.055 Impact Factor

Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

J Clin Invest 2008 Oct;118(10):3331-42

Division of Gastroenterology, Department of Medicine, Duke University Medical Center, and Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI35875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542850PMC
October 2008
22 Reads
133 Citations
13.215 Impact Factor

Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.

Gastroenterology 2008 Aug 16;135(2):660-70. Epub 2008 Apr 16.

Institute of Clinical Pharmacology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505071PMC
August 2008
36 Reads
68 Citations
16.720 Impact Factor

Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

J Hepatol 2008 Mar 14;48(3):453-64. Epub 2008 Jan 14.

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2007.11.021DOI Listing
March 2008
49 Reads
49 Citations
11.340 Impact Factor

Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro.

J Hepatol 2007 May 12;46(5):878-87. Epub 2006 Dec 12.

Institute of Clinical Pharmacology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2006.11.011DOI Listing
May 2007
12 Reads
19 Citations
11.340 Impact Factor

Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.

J Biol Chem 2006 Jun 17;281(22):15090-8. Epub 2006 Feb 17.

Department of Medicine I, University of Erlangen-Nuernberg, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M600030200
Publisher Site
http://dx.doi.org/10.1074/jbc.M600030200DOI Listing
June 2006
27 Reads
33 Citations
4.573 Impact Factor

Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.

J Hepatol 2005 Dec 15;43(6):1045-54. Epub 2005 Aug 15.

Laboratory of Liver Research, Department of Medicine I, University of Erlangen-Nuremberg, Germany; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2005.06.025DOI Listing
December 2005
19 Reads
69 Citations
11.340 Impact Factor

Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat.

Hepatology 2005 Nov;42(5):1072-81

Department of Medicine, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20889DOI Listing
November 2005
36 Reads
24 Citations
11.055 Impact Factor

Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells.

Gastroenterology 2005 Jul;129(1):246-58

Department of Medicine I, University of Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
July 2005
34 Reads
32 Citations
16.720 Impact Factor

Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential.

FASEB J 2005 May 24;19(7):845-7. Epub 2005 Feb 24.

Laboratory of Liver Research, Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.04-2809fjeDOI Listing
May 2005
24 Reads
14 Citations
5.043 Impact Factor

Hepatic fibrosis: from bench to bedside.

J Gastroenterol Hepatol 2002 Dec;17 Suppl 3:S300-5

Department of Medicine I, Division of Gastroenterology, Hepatology and Infectiology, University of Erlangen-Nuernberg, Germany.

View Article

Download full-text PDF

Source
December 2002
9 Reads
13 Citations
3.504 Impact Factor

Scavenging and antioxidant effects of estrogen derivatives in cholesterol-fed rabbits.

Adv Exp Med Biol 2001 ;500:267-70

Institute of Biochemistry, Grodno, Belarus.

View Article

Download full-text PDF

Source
July 2002
3 Reads

Antiatherogenic effects of 17 beta-estradiol and 17 alpha-estradiol and its derivative J811 in cholesterol-fed rabbits with thyroid inhibition.

Buko VU, Lukivskaya O, Naruta E, Popov Y, Chirkin A, Chirkina I, Oettel M, Römer W, Hübler D, Climacteric : the journal of the International Menopause Society, 2001, vol. 4, no. 1, pp. 49-57

http://europepmc.org/abstract/med/11379378

View Article
March 2001
5 Reads

Mouse model of PBC with progressive fibrosis: Are we there yet?

Yury Popov, 2012, 'Mouse model of PBC with progressive fibrosis: Are we there yet?', Hepatology

View Article
1969
4 Reads

CD8+ T cells drive adipose tissue inflammation – A novel clue for NASH pathogenesis?

Yury Popov, Detlef Schuppan, 2010, 'CD8+ T cells drive adipose tissue inflammation – A novel clue for NASH pathogenesis?', Journal of Hepatology, vol. 52, no. 1

View Article
1969
5 Reads